Your browser doesn't support javascript.
loading
A structured approach to choosing estimands and estimators in longitudinal clinical trials.
Mallinckrodt, C H; Lin, Q; Lipkovich, I; Molenberghs, G.
Affiliation
  • Mallinckrodt CH; Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285, USA. cmallinc@lilly.com
Pharm Stat ; 11(6): 456-61, 2012.
Article in En | MEDLINE | ID: mdl-22962024
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Investigational / Clinical Trials as Topic / Models, Statistical Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Pharm Stat Journal subject: FARMACOLOGIA Year: 2012 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Investigational / Clinical Trials as Topic / Models, Statistical Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Pharm Stat Journal subject: FARMACOLOGIA Year: 2012 Document type: Article Affiliation country: